Tradestie Institutional Equity Comparison Engine

VRAX vs REVB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

REVB Overall Edge

REVB Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Revelation Biosciences, Inc. Common Stock (REVB) driven by superior Valuation, Momentum & Technical while VRAX counters with relative strength in Growth & Margin. Fundamentally, VRAX trades at N/M Forward P/E with -51515.2% operating margin (+684.9% YoY revenue) versus REVB at 0.9x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VRAX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against REVB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner REVB
VRAX N/M vs REVB 0.9x Fwd P/E
Growth & Margin Winner VRAX
Op Margin -51515.2% vs 0.0% ยท YoY +684.9% vs +0.0%
Momentum & Technical Winner REVB
1Y -6.5% vs +332.7% ยท 52W Pos 3% vs 80%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
VRAX NASDAQ
Virax Biolabs Group Limited Ordinary Shares
In Vitro & In Vivo Diagnostic Substances
$0.46
+2.46% 1D
Market Cap $823,939
1M Return -67.21%
1Y Return -6.52%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0
REVB NASDAQ
Revelation Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$3.89
+1.83% 1D
Market Cap $2.4M
1M Return +728.89%
1Y Return +332.7%
Forward P/E 0.9x
Unified AI Score
34.4 / 100 SELL
Tech 8.0 Fund 23.0 Flow 50.0 Mom 11.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VRAX -6.52% REVB +332.7% Spread: +339.22 pp (REVB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VRAX TTM Op. Margin: -51515.2% REVB TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VRAX vs REVB. Trailing 12-month operating profitability (VRAX -51515.2% vs REVB 0.0%) and valuation multiples (VRAX N/M vs REVB 0.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VRAX (4) vs REVB (4)
Institutional Metric VRAX REVB Criterion Row Winner
Market Capitalization Scale $823,939 $2.4M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 0.9x Lower Multiple REVB
Forward P/E Ratio Valuation N/M 0.9x Lower Multiple REVB
Revenue Growth (YoY) Growth +684.9% +0.0% Higher Growth VRAX
Operating Margin (TTM) Profitability -51515.2% 0.0% Higher Margin REVB
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -78.6% -133.4% Higher ROE VRAX
52-Week Range Position Momentum 3% ($0โ€“$13) 80% ($0โ€“$5) Stronger Trend REVB
Beta / 30D Volatility Risk Regime -9.35ฮฒ ยท 161% Vol 2.95ฮฒ ยท 2364% Vol Lower Realized Risk VRAX
Unified Institutional Score Composite Signal 41.7 / 100 (SELL) 34.4 / 100 (SELL) Higher Composite VRAX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VRAX vs REVB Buy Guide
VRAX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VRAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
REVB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live REVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VRAX nor REVB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.